|
 |
 |
 |
 |
 |
 |
 |
|
     |
 |
press release, November 2001 SCIMCON expands I.S. Strategy for Biotech & Drug discovery According to Accenture (formerly Anderson Consulting), a doubling of output of approved New Chemical Entities (NCEs) is expected to be the norm in this decade. In this increasingly rapid-paced biotechnology and drug discovery environment, research and pharmaceutical organisations alike are facing the same crises to support their ambitious targets. Development programs of this scale produce other pressures, such as:
The effect of these demands is that timelines and costs are increased - for example 6-10 times the number of NCEs will need to be delivered to achieve 10% annual growth*. In this environment, SCIMCON, the Cambridge, UK-based Scientific Information Management Consultancy, is being increasingly called on to address the requirement for comprehensive Information System (IS) strategies that support growing biotech organisations. The creation and adoption of the correct IS strategy is vital if laboratories are to achieve their objectives. SCIMCON work closely with all levels of their client's organisation to design and implement an IS strategy which meets their on going needs. Strategies typically cover the creation of a project infrastructure, encompassing project proposals and project prioritisation in support of the business objectives, documenting the route a project must take to gain approval. Additionally, a strategy standardises the company's approach to requirements gathering techniques, project initiation, management and change control procedures. Utilising an agreed IS strategy, SCIMCON can undertake a review of existing and proposed systems to ensure effective solutions are delivered which support the client's short, medium and long term objectives. The need to discover increasing numbers of NCEs and rapidly submit patents coupled with regulatory issues such as the pharmaceutical industry gearing up for 2003, when the FDA is scheduled to be ready for electronic submissions, means that effective information system strategies, are now more important then ever. (*Source: Lehman Brothers report 'Winners and Losers in the R&D Productivity' and Accenture analysis). For more information please contact Scimcon on +44 (0) 1638 720204 or visit the website www.scimcon.com. read other recent press releases>> |
||
|
Scimcon Limited, Registered in Cardiff No 4844956, Registered Office: 57 London Road, High Wycombe, Bucks, HP11 1BS |
||||